Exact Mass: 620.44

Ginsenoside Rh4

C36H60O8 (620.4288)

Ginsenoside Rh4 is found in tea. Ginsenoside Rh4 is isolated from ginseng. Isolated from ginseng. Ginsenoside Rh4 is found in tea.

Soyasapogenol B 24-O-b-D-glucoside

C36H60O8 (620.4288)

Soyasapogenol B 24-O-b-D-glucoside is found in pulses. Soyasapogenol B 24-O-b-D-glucoside is a constituent of French bean seeds (Phaseolus vulgaris). Constituent of French bean seeds (Phaseolus vulgaris). Soyasapogenol B 24-O-b-D-glucoside is found in pulses, yellow wax bean, and green bean.

(3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside

C36H60O8 (620.4288)

(3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside is found in fruits. (3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside is a constituent of Momordica charantia (bitter melon). Constituent of Momordica charantia (bitter melon). (3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside is found in fruits.

Fasciculic acid A

C36H60O8 (620.4288)

Fasciculic acid A is found in mushrooms. Fasciculic acid A is from the toxic sulphur tuft mushroom Naematoloma fasciculare. From the toxic sulphur tuft mushroom Naematoloma fasciculare. Fasciculic acid A is found in mushrooms.

Mosinone A

C37H64O7 (620.4652)

Mosinone A is found in fruits. Mosinone A is a constituent of Annona squamosa (sugar apple) Constituent of Annona squamosa (sugar apple). Mosinone A is found in fruits.

PA(8:0/22:0)

C33H65O8P (620.4417)

PA(8:0/22:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/22:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of behenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(16:0/14:0)

C33H65O8P (620.4417)

PA(16:0/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/14:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(20:0/10:0)

C33H65O8P (620.4417)

PA(20:0/10:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/10:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of capric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(22:0/8:0)

C33H65O8P (620.4417)

PA(22:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:0/8:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(10:0/i-20:0)

C33H65O8P (620.4417)

PA(10:0/i-20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-20:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isoeicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/i-22:0)

C33H65O8P (620.4417)

PA(8:0/i-22:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-22:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isodocosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(a-13:0/a-17:0)

C33H65O8P (620.4417)

PA(a-13:0/a-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/a-17:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of anteisoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(a-13:0/i-17:0)

C33H65O8P (620.4417)

PA(a-13:0/i-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-17:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-12:0/i-18:0)

C33H65O8P (620.4417)

PA(i-12:0/i-18:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-18:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isooctadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-13:0/a-17:0)

C33H65O8P (620.4417)

PA(i-13:0/a-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/a-17:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of anteisoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-13:0/i-17:0)

C33H65O8P (620.4417)

PA(i-13:0/i-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-17:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-14:0/i-16:0)

C33H65O8P (620.4417)

PA(i-14:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-16:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-20:0/10:0)

C33H65O8P (620.4417)

PA(i-20:0/10:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-20:0/10:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position and one chain of capric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-22:0/8:0)

C33H65O8P (620.4417)

PA(i-22:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-22:0/8:0), in particular, consists of one chain of isodocosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.4288)

DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/13:0/0:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.4288)

DG(13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/13:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C37H64O7 (620.4652)

DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0)

C37H64O7 (620.4652)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C37H64O7 (620.4652)

DG(14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/14:0)

C37H64O7 (620.4652)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.4288)

DG(a-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-13:0/0:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.4288)

DG(a-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/a-13:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.4288)

DG(i-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-13:0/0:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.4288)

DG(i-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-13:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C37H64O7 (620.4652)

DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0)

C37H64O7 (620.4652)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C37H64O7 (620.4652)

DG(i-14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-14:0)

C37H64O7 (620.4652)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C37H64O7 (620.4652)

DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0)

C37H64O7 (620.4652)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C37H64O7 (620.4652)

DG(i-14:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-14:0)

C37H64O7 (620.4652)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C37H64O7 (620.4652)

DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0)

C37H64O7 (620.4652)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C37H64O7 (620.4652)

DG(i-14:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-14:0)

C37H64O7 (620.4652)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

3-O-(beta-D-Glucopyranosyl)-soyasapogenol B

C36H60O8 (620.4288)

3-o-(beta-d-glucopyranosyl)-soyasapogenol b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 3-o-(beta-d-glucopyranosyl)-soyasapogenol b can be found in soy bean, which makes 3-o-(beta-d-glucopyranosyl)-soyasapogenol b a potential biomarker for the consumption of this food product.

cimigenol 3AAP

C35H56O9 (620.3924)

Cimiracemoside C is a natural product found in Actaea dahurica, Actaea elata, and other organisms with data available. See also: Black Cohosh (part of).

Ginsenoside Rk3

C36H60O8 (620.4288)

Ginsenoside Rk3 is a natural product found in Panax ginseng and Panax notoginseng with data available. Ginsenoside Rk3 is present in the roots Panax ginseng herbs. Ginsenoside Rk3 significantly inhibits TNF-α-induced NF-κB transcriptional activity, with an IC50 of 14.24±1.30 μM in HepG2 cells. Ginsenoside Rk3 is present in the roots Panax ginseng herbs. Ginsenoside Rk3 significantly inhibits TNF-α-induced NF-κB transcriptional activity, with an IC50 of 14.24±1.30 μM in HepG2 cells.

Ginsenoside RH4

C36H60O8 (620.4288)

Ginsenoside Rh4 is a triterpenoid saponin. Ginsenoside Rh4 is a natural product found in Panax vietnamensis and Panax notoginseng with data available.

Cimigoside

C35H56O9 (620.3924)

Cimigenol 3-O-beta-D-xylopyranoside is a cucurbitacin and a glycoside. It has a role as a metabolite. Cimigenoside is a natural product found in Actaea pachypoda, Actaea dahurica, and other organisms with data available. See also: Black Cohosh (part of). Cimigenoside is an active compound from genus Cimicifuga[1]. Cimigenoside is an active compound from genus Cimicifuga[1].

Rubianoside II

C36H60O8 (620.4288)

Sipholenoside A

C36H60O8 (620.4288)

Cimiaceroside B

C35H56O9 (620.3924)

Cauloside B

C35H56O9 (620.3924)

FT-0775632

C36H60O8 (620.4288)

Cimicifugoside M

C35H56O9 (620.3924)

3beta,23,28-Trihydroxy-12-oleanene 3beta-caffeate

C39H56O6 (620.4077)

Podocarpaside D

C35H56O9 (620.3924)

Guanacone

C37H64O7 (620.4652)

3beta,23,28-Trihydroxy-12-oleanene 23-caffeate

C39H56O6 (620.4077)

Goniocin

C37H64O7 (620.4652)

Aromicin

C37H64O7 (620.4652)

Podocarpaside B

C35H56O9 (620.3924)

Annomosin A

C40H60O5 (620.4441)

Rakicidin B

C33H56N4O7 (620.4149)

3-O-(beta-D-Glucopyranosyl)-soyasapogenol B

C36H60O8 (620.4288)

Staphinine

C42H56N2O2 (620.4342)

Staphirine

C42H56N2O2 (620.4342)

gagunin M

C35H56O9 (620.3924)

(2E)-6-{13,17-dihydroxy-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}-2-methylhept-2-enoic acid

C35H56O9 (620.3924)

cimigenoside

C35H56O9 (620.3924)

androseptoside B

C36H60O8 (620.4288)

Panacon

C37H64O7 (620.4652)

Mirabimide A

C33H56N4O7 (620.4149)

4,6,8,10,12,14,16,18,20-Nonamethoxy-1-pentacosene

C34H68O9 (620.4863)

Cycloartanol ferulate

C41H64O4 (620.4804)

23,28-dihydroxylupan-12-ene-3beta-caffeate

C39H56O6 (620.4077)

alnustic acid 12-O-alpha-L-arabinofuranoside

C36H60O8 (620.4288)

3-[[12-acetyloxy-17-(2,5-dihydroxy-6-methylhept-6-en-2-yl)-17-hydroxy-4,4,8,10,14-pentamethyl-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3-oxopropanoic acid

C35H56O9 (620.3924)

1-[3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy]octacosane-3,25,27-triol

C34H68O9 (620.4863)

12-O-beta-D-xylopyranoside of alnustic acid

C36H60O8 (620.4288)

Tomentoside I

C35H56O9 (620.3924)

3-[13-Hydroxy-13-[[5-(1-hydroxy-5-oxoundecyl)octahydro-2,2-bifuran]-5-yl]tridecyl]-5-methylfuran-2(5H)-one

C37H64O7 (620.4652)

2alpha,3beta,19alpha-trihydroxy-olean-12-en-17-oic acid-28-O-beta-D-xylopyranoside

C35H56O9 (620.3924)

olean-12-ene-3beta,19beta,24-triol-3-O-beta-D-glucopyranoside|sigmoiside F

C36H60O8 (620.4288)

C35H56O9

C35H56O9 (620.3924)

20(S),22(R),23(R),24(S)-16beta:23beta,23alpha:24alpha-diepoxy-3beta,22beta,25-trihydroxy-9,19-cyclolanostane 3-O-beta-D-xylopyranoside|rubraside A

C35H56O9 (620.3924)

3beta,19,25-trihydroxy-16,23-dioneranuncul-9(10)-ene 3-O-alpha-L-arabinopyranoside|podocarpaside|ranunculane

C35H56O9 (620.3924)

C32H60O11

C32H60O11 (620.4135)

Obtusilic acid

C39H56O6 (620.4077)

Cycloalpioside A

C35H56O9 (620.3924)

C36H60O8

C36H60O8 (620.4288)

4,6,8,10,12,14,16,18,22-Nonamethoxy-1-pentacosene

C34H68O9 (620.4863)

24-methylenecycloartane-3beta,6beta,7beta16beta-tetraol 3-Obeta-D-xylopyranoside

C36H60O8 (620.4288)

bafilomycin J

C36H60O8 (620.4288)

3beta,20(S)-dihydroxydammar-24-en-12beta,23beta-epoxy-20-O-beta-D-glucopyranoside

C36H60O8 (620.4288)

lup-20(29)en-2,28-diol-3-yl caffeate

C39H56O6 (620.4077)

3-beta,23,28-trihydroxy-olean-12-en-3-O-beta-D-glucopyranoside

C36H60O8 (620.4288)

C39H56O6

C39H56O6 (620.4077)

2-methoxy-4-carbomethoxyphenyl 3beta-hydroxylup-20(29)-en-28-oate

C39H56O6 (620.4077)

5alpha,8alpha-Peroxyergosteryldivaricatinat

C39H56O6 (620.4077)

3beta-O-trans-caffeoyl-29-hydroxybetulin

C39H56O6 (620.4077)

joolanin

C37H64O7 (620.4652)

soyasapogenol B-22-O-beta-D-glucoside

C36H60O8 (620.4288)

martinelline

C33H52N10O2 (620.4274)

23,28-dihydroxyursen-12-ene-3beta-caffeate

C39H56O6 (620.4077)

PA(15:0/15:0)[U]

C33H65O8P (620.4417)

1-(O-alpha-D-glucopyranosyl)-(1,3R,25S,27R)-octacosanetetraol

C34H68O9 (620.4863)

1-(O-alpha-D-mannopyranosyl)-(1,3R,25S,27R)-octacosanetetraol

C34H68O9 (620.4863)

1-(6-[5]-ladderane-hexanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerol

C41H64O4 (620.4804)

PA(18:0/12:0)

C33H65O8P (620.4417)

PA(17:0/13:0)

C33H65O8P (620.4417)

PA(13:0/17:0)

C33H65O8P (620.4417)

PA(12:0/18:0)

C33H65O8P (620.4417)

PA(16:0/14:0)

C33H65O8P (620.4417)

PA(15:0/15:0)

C33H65O8P (620.4417)

PA(14:0/16:0)

C33H65O8P (620.4417)

PA(O-16:0/15:0)

C34H69O7P (620.4781)

PA(O-18:0/13:0)

C34H69O7P (620.4781)

Mosinone A

C37H64O7 (620.4652)

Fasciculic acid A

C36H60O8 (620.4288)

(3b,7b,22x)-Cucurbita-5,24-diene-3,7,23-triol 7-glucoside

C36H60O8 (620.4288)

3-DPHMC

C36H60O8 (620.4288)

N-lignoceroyl-O-phosphocholineserine

C32H65N2O7P (620.4529)

1-(O-alpha-D-glucopyranosyl)-(1,3R,25S,27R)-octacosanetetrol

C34H68O9 (620.4863)

1-(O-alpha-D-mannopyranosyl)-(1,3R,25S,27R)-octacosanetetrol

C34H68O9 (620.4863)

1-(O-6-O-methyl-beta-D-glucopyranose)-3,25,27-octacosanetriol

C34H68O9 (620.4863)

DG O-38:9

C41H64O4 (620.4804)

PA 30:0

C33H65O8P (620.4417)

PA O-31:0

C34H69O7P (620.4781)

Butyl 4-O-hexadecanoyl-neohesperidoside

C32H60O11 (620.4135)

2-[2-[2-[2-[2-[2-[2-(2-octadec-9-enoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol

C34H68O9 (620.4863)

6-O-beta-D-glucopyranosyldammar-20(22),24-diene-3beta,6alpha,12beta-triol

C36H60O8 (620.4288)

Sigmoside C

C36H60O8 (620.4288)

3-Glc-soyasapogenol B

C36H60O8 (620.4288)

23-Glc-soyasapogenol B

C36H60O8 (620.4288)

DG(14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C37H64O7 (620.4652)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/14:0/0:0)

C37H64O7 (620.4652)

DG(14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C37H64O7 (620.4652)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/14:0)

C37H64O7 (620.4652)

DG(i-14:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C37H64O7 (620.4652)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-14:0/0:0)

C37H64O7 (620.4652)

DG(i-14:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C37H64O7 (620.4652)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-14:0)

C37H64O7 (620.4652)

DG(i-14:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C37H64O7 (620.4652)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-14:0/0:0)

C37H64O7 (620.4652)

DG(i-14:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C37H64O7 (620.4652)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-14:0)

C37H64O7 (620.4652)

DG(i-14:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C37H64O7 (620.4652)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-14:0/0:0)

C37H64O7 (620.4652)

DG(i-14:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C37H64O7 (620.4652)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-14:0)

C37H64O7 (620.4652)

DG(13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/13:0/0:0)

C36H60O8 (620.4288)

DG(13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/13:0)

C36H60O8 (620.4288)

DG(a-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-13:0/0:0)

C36H60O8 (620.4288)

DG(a-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/a-13:0)

C36H60O8 (620.4288)

DG(i-13:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-13:0/0:0)

C36H60O8 (620.4288)

DG(i-13:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C36H60O8 (620.4288)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-13:0)

C36H60O8 (620.4288)

12-Deoxyfasciculic acid B

C36H60O8 (620.4288)

(5R,6S,7S)-5,6-dihydroxy-N-nonyl-7-(octanoylamino)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name)

C31H60N2O10 (620.4248)

2-[hydroxy-[(2R)-3-[(Z)-octadec-9-enoyl]oxy-2-(5-oxopentanoyloxy)propoxy]phosphoryl]oxyethyl-trimethylazanium

C31H59NO9P+ (620.3927)

(2S)-2-[(3S,9E,14S)-7,14-dimethyl-15-[(2R)-15-methylhexadecan-2-yl]-11-methylidene-2,5,8,13-tetraoxo-1-oxa-4,7,12-triazacyclopentadec-9-en-3-yl]-2-hydroxyacetamide

C33H56N4O7 (620.4149)

2,3-bis[[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy]propyl (3Z,6Z,9Z)-dodeca-3,6,9-trienoate

C39H56O6 (620.4077)

NAGlySer 17:2/13:1

C35H60N2O7 (620.44)

NAGlySer 16:2/14:1

C35H60N2O7 (620.44)

NAGlySer 12:0/18:3

C35H60N2O7 (620.44)

NAGlySer 14:1/16:2

C35H60N2O7 (620.44)

NAGlySer 13:1/17:2

C35H60N2O7 (620.44)

NAGlySer 20:3/10:0

C35H60N2O7 (620.44)

NAGlySer 16:3/14:0

C35H60N2O7 (620.44)

NAGlySer 14:0/16:3

C35H60N2O7 (620.44)

NAGlySer 18:3/12:0

C35H60N2O7 (620.44)

NAGlySer 10:0/20:3

C35H60N2O7 (620.44)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (15Z,18Z)-hexacosa-15,18-dienoate

C32H61O9P (620.4053)

PE-Cer 12:2;2O/20:5

C34H57N2O6P (620.3954)

PE-Cer 14:2;2O/18:5

C34H57N2O6P (620.3954)

PE-Cer 14:3;2O/18:4

C34H57N2O6P (620.3954)

PE-Cer 16:3;2O/16:4

C34H57N2O6P (620.3954)

PE-Cer 18:1;2O/12:0;O

C32H65N2O7P (620.4529)

PE-Cer 16:1;2O/14:0;O

C32H65N2O7P (620.4529)

PE-Cer 12:1;2O/18:0;O

C32H65N2O7P (620.4529)

PE-Cer 13:1;2O/17:0;O

C32H65N2O7P (620.4529)

PE-Cer 15:0;2O/15:1;O

C32H65N2O7P (620.4529)

PE-Cer 14:1;2O/16:0;O

C32H65N2O7P (620.4529)

PE-Cer 18:0;2O/12:1;O

C32H65N2O7P (620.4529)

PE-Cer 12:0;2O/18:1;O

C32H65N2O7P (620.4529)

PE-Cer 17:1;2O/13:0;O

C32H65N2O7P (620.4529)

PE-Cer 17:0;2O/13:1;O

C32H65N2O7P (620.4529)

PE-Cer 16:0;2O/14:1;O

C32H65N2O7P (620.4529)

PE-Cer 14:0;2O/16:1;O

C32H65N2O7P (620.4529)

PE-Cer 15:1;2O/15:0;O

C32H65N2O7P (620.4529)

[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C41H64O4 (620.4804)

[1-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C41H64O4 (620.4804)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C41H64O4 (620.4804)

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C41H64O4 (620.4804)

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C41H64O4 (620.4804)

[1-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C41H64O4 (620.4804)

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C41H64O4 (620.4804)

[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C41H64O4 (620.4804)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] decanoate

C32H61O9P (620.4053)

[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C32H61O9P (620.4053)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

C32H61O9P (620.4053)

Fahfa 41:8

C41H64O4 (620.4804)

Phosphoric acid ethyl 2,3-bis(1-oxotetradecyloxy)propyl-ester

C33H65O8P (620.4417)

PMeOH 12:0_17:0

C33H65O8P (620.4417)

PEtOH 13:0_15:0

C33H65O8P (620.4417)

PMeOH 14:0_15:0

C33H65O8P (620.4417)

PEtOH 12:0_16:0

C33H65O8P (620.4417)

PMeOH 13:0_16:0

C33H65O8P (620.4417)

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) hexacosanoate

C33H65O8P (620.4417)

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

C33H65O8P (620.4417)

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

C33H65O8P (620.4417)

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

C33H65O8P (620.4417)

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

C33H65O8P (620.4417)

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) heptacosanoate

C33H65O8P (620.4417)

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

C33H65O8P (620.4417)

(2-Pentadecanoyloxy-3-phosphonooxypropyl) pentadecanoate

C33H65O8P (620.4417)

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) heptadecanoate

C33H65O8P (620.4417)

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

C33H65O8P (620.4417)

(1-Phosphonooxy-3-tetradecanoyloxypropan-2-yl) hexadecanoate

C33H65O8P (620.4417)

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

C33H65O8P (620.4417)

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) nonadecanoate

C33H65O8P (620.4417)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoate

C40H60O5 (620.4441)

2-[[(2R)-3-decanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] nonadecanoate

C33H65O8P (620.4417)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoate

C40H60O5 (620.4441)

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] icosanoate

C33H65O8P (620.4417)

2-[[(2R)-2-decanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[3-decanoyloxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[2-decanoyloxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] nonadecanoate

C33H65O8P (620.4417)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

2-[hydroxy-[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

2-[[3-butanoyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

2-[[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

2-[[3-hexanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

2-[[3-[(Z)-hexadec-9-enoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

2-[hydroxy-[3-[(Z)-tetradec-9-enoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

[3-[3-acetyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C36H62NO7+ (620.4526)

2-[[3-acetyloxy-2-[(Z)-docos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

[3-[3-butanoyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[3-decanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

[1-carboxy-3-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-octanoyloxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

2-[hydroxy-[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-heptanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

2-[[2-[(Z)-henicos-11-enoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

[1-carboxy-3-[3-hexanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C36H62NO7+ (620.4526)

2-[[2-heptanoyloxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H63NO8P+ (620.4291)

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-octoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[carboxy-[3-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium

C36H62NO7+ (620.4526)

2-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-undecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[2-hexanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[2-butanoyloxy-3-[(Z)-henicos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[2-decanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[3-decoxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[3-dodecoxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[3-[(Z)-heptadec-9-enoxy]-2-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[3-[(Z)-docos-13-enoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[2-dodecanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H67NO7P+ (620.4655)

1-Hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phosphate

C33H65O8P (620.4417)

A 1-acyl-2-tetradecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as hexadecanoyl (palmitoyl).

Soyasapogenol B 24-O-b-D-glucoside

C36H60O8 (620.4288)

1-hexadecyl-2-pentadecanoyl-glycero-3-phosphate

C34H69O7P (620.4781)

1,2-dipentadecanoyl-sn-glycero-3-phosphate

C33H65O8P (620.4417)

TG(37:9)

C40H60O5 (620.4441)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 15:1/O-26:7

C41H64O4 (620.4804)

FAHFA 15:2/O-26:6

C41H64O4 (620.4804)

FAHFA 15:3/O-26:5

C41H64O4 (620.4804)

FAHFA 15:4/O-26:4

C41H64O4 (620.4804)

FAHFA 15:5/O-26:3

C41H64O4 (620.4804)

FAHFA 16:1/O-25:7

C41H64O4 (620.4804)

FAHFA 16:2/O-25:6

C41H64O4 (620.4804)

FAHFA 16:3/O-25:5

C41H64O4 (620.4804)

FAHFA 16:4/O-25:4

C41H64O4 (620.4804)

FAHFA 16:5/O-25:3

C41H64O4 (620.4804)

FAHFA 17:1/O-24:7

C41H64O4 (620.4804)

FAHFA 17:2/O-24:6

C41H64O4 (620.4804)

FAHFA 17:3/O-24:5

C41H64O4 (620.4804)

FAHFA 17:4/O-24:4

C41H64O4 (620.4804)

FAHFA 17:5/O-24:3

C41H64O4 (620.4804)

FAHFA 18:1/O-23:7

C41H64O4 (620.4804)

FAHFA 18:2/O-23:6

C41H64O4 (620.4804)

FAHFA 18:3/O-23:5

C41H64O4 (620.4804)

FAHFA 18:4/O-23:4

C41H64O4 (620.4804)

FAHFA 18:5/O-23:3

C41H64O4 (620.4804)

FAHFA 18:6/O-23:2

C41H64O4 (620.4804)

FAHFA 19:1/O-22:7

C41H64O4 (620.4804)

FAHFA 19:2/O-22:6

C41H64O4 (620.4804)

FAHFA 19:3/O-22:5

C41H64O4 (620.4804)

FAHFA 19:4/O-22:4

C41H64O4 (620.4804)

FAHFA 19:5/O-22:3

C41H64O4 (620.4804)

FAHFA 19:6/O-22:2

C41H64O4 (620.4804)

FAHFA 20:1/O-21:7

C41H64O4 (620.4804)

FAHFA 20:2/O-21:6

C41H64O4 (620.4804)

FAHFA 20:3/O-21:5

C41H64O4 (620.4804)

FAHFA 20:4/O-21:4

C41H64O4 (620.4804)

FAHFA 20:5/O-21:3

C41H64O4 (620.4804)

FAHFA 20:6/O-21:2

C41H64O4 (620.4804)

FAHFA 21:2/O-20:6

C41H64O4 (620.4804)

FAHFA 21:3/O-20:5

C41H64O4 (620.4804)

FAHFA 21:4/O-20:4

C41H64O4 (620.4804)

FAHFA 21:5/O-20:3

C41H64O4 (620.4804)

FAHFA 21:6/O-20:2

C41H64O4 (620.4804)

FAHFA 21:7/O-20:1

C41H64O4 (620.4804)

FAHFA 22:2/O-19:6

C41H64O4 (620.4804)

FAHFA 22:3/O-19:5

C41H64O4 (620.4804)

FAHFA 22:4/O-19:4

C41H64O4 (620.4804)

FAHFA 22:5/O-19:3

C41H64O4 (620.4804)

FAHFA 22:6/O-19:2

C41H64O4 (620.4804)

FAHFA 22:7/O-19:1

C41H64O4 (620.4804)

FAHFA 23:2/O-18:6

C41H64O4 (620.4804)

FAHFA 23:3/O-18:5

C41H64O4 (620.4804)

FAHFA 23:4/O-18:4

C41H64O4 (620.4804)

FAHFA 23:5/O-18:3

C41H64O4 (620.4804)

FAHFA 23:6/O-18:2

C41H64O4 (620.4804)

FAHFA 23:7/O-18:1

C41H64O4 (620.4804)

FAHFA 24:3/O-17:5

C41H64O4 (620.4804)

FAHFA 24:4/O-17:4

C41H64O4 (620.4804)

FAHFA 24:5/O-17:3

C41H64O4 (620.4804)

FAHFA 24:6/O-17:2

C41H64O4 (620.4804)

FAHFA 24:7/O-17:1

C41H64O4 (620.4804)

FAHFA 25:3/O-16:5

C41H64O4 (620.4804)

FAHFA 25:4/O-16:4

C41H64O4 (620.4804)

FAHFA 25:5/O-16:3

C41H64O4 (620.4804)

FAHFA 25:6/O-16:2

C41H64O4 (620.4804)

FAHFA 25:7/O-16:1

C41H64O4 (620.4804)

FAHFA 26:3/O-15:5

C41H64O4 (620.4804)

FAHFA 26:4/O-15:4

C41H64O4 (620.4804)

FAHFA 26:5/O-15:3

C41H64O4 (620.4804)

FAHFA 26:6/O-15:2

C41H64O4 (620.4804)

FAHFA 26:7/O-15:1

C41H64O4 (620.4804)

FAHFA 41:8;O

C41H64O4 (620.4804)

MGDG O-24:0;O

C33H64O10 (620.4499)

LPA 31:0

C34H69O7P (620.4781)

PA O-14:0/17:0

C34H69O7P (620.4781)

PA O-16:0/15:0

C34H69O7P (620.4781)

PA O-18:0/13:0

C34H69O7P (620.4781)

PA O-20:0/11:0

C34H69O7P (620.4781)

PA O-29:2;O2

C32H61O9P (620.4053)

PA P-20:0/9:1;O2

C32H61O9P (620.4053)

PA 20:0/9:1;O

C32H61O9P (620.4053)

PA 29:1;O

C32H61O9P (620.4053)

PA 10:0_20:0

C33H65O8P (620.4417)

PA 11:0_19:0

C33H65O8P (620.4417)

PA 12:0_18:0

C33H65O8P (620.4417)

PA 13:0_17:0

C33H65O8P (620.4417)

PA 14:0_16:0

C33H65O8P (620.4417)

PA 15:0/15:0

C33H65O8P (620.4417)

PA 26:0/4:0

C33H65O8P (620.4417)

PA 28:0/2:0

C33H65O8P (620.4417)

LPG 26:2

C32H61O9P (620.4053)

PG O-16:2/10:0

C32H61O9P (620.4053)

PG O-22:1/4:1

C32H61O9P (620.4053)

PG O-22:2/4:0

C32H61O9P (620.4053)

PG O-26:2

C32H61O9P (620.4053)

PG P-16:1/10:0

C32H61O9P (620.4053)

PG P-16:1/10:0 or PG O-16:2/10:0

C32H61O9P (620.4053)

PG P-22:0/4:1

C32H61O9P (620.4053)

PG P-22:0/4:1 or PG O-22:1/4:1

C32H61O9P (620.4053)

PG P-22:1/4:0

C32H61O9P (620.4053)

PG P-22:1/4:0 or PG O-22:2/4:0

C32H61O9P (620.4053)

PG P-26:1

C32H61O9P (620.4053)

PG P-26:1 or PG O-26:2

C32H61O9P (620.4053)

LPEth 29:0

C34H69O7P (620.4781)

LPM 30:0

C34H69O7P (620.4781)

PEth 27:1;O

C32H61O9P (620.4053)

PEth 28:0

C33H65O8P (620.4417)

PM 28:1;O

C32H61O9P (620.4053)

PM 29:0

C33H65O8P (620.4417)

CerPE 12:0;O2/18:1;O

C32H65N2O7P (620.4529)

CerPE 14:1;O2/16:0;O

C32H65N2O7P (620.4529)

CerPE 15:1;O2/15:0;O

C32H65N2O7P (620.4529)

CerPE 16:1;O2/14:0;O

C32H65N2O7P (620.4529)

CerPE 17:1;O2/13:0;O

C32H65N2O7P (620.4529)

CerPE 18:1;O2/12:0;O

C32H65N2O7P (620.4529)

CerPE 19:1;O2/11:0;O

C32H65N2O7P (620.4529)

CerPE 20:1;O2/10:0;O

C32H65N2O7P (620.4529)

CerPE 30:1;O2;O

C32H65N2O7P (620.4529)

SM 14:1;O2/13:0;O

C32H65N2O7P (620.4529)

SM 15:1;O2/12:0;O

C32H65N2O7P (620.4529)

SM 16:1;O2/11:0;O

C32H65N2O7P (620.4529)

SM 17:1;O2/10:0;O

C32H65N2O7P (620.4529)

SM 27:1;O2;O

C32H65N2O7P (620.4529)

(1r,3as,5ar,5br,7ar,8r,9s,11ar,11br,13ar,13br)-3a,8-bis(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

(7s,9bs,11ar)-9b-ethyl-3a,6,6,11a-tetramethyl-1-(6-methylheptan-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C41H64O4 (620.4804)

2-[(3s,14s,15s)-15-(heptadecan-2-yl)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C33H56N4O7 (620.4149)

2-(hydroxymethyl)-6-[(3,25,27-trihydroxyoctacosyl)oxy]oxane-3,4,5-triol

C34H68O9 (620.4863)

[(1s,4s,5r,9s,10r,13r,14s)-5-formyl-14-hydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl (1r,4s,5r,9s,10r,13r,14r)-5-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate

C40H60O5 (620.4441)

7-hydroxy-2,2,5a,7-tetramethyl-6-(2-{1,4,4,6-tetramethyl-1-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-hexahydro-2h-azulen-5-ylidene}ethyl)-hexahydro-1-benzoxepin-3-one

C36H60O8 (620.4288)

3-[(3s,3as,4r,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C36H60O8 (620.4288)

{5-formyl-14-hydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl}methyl 5-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate

C40H60O5 (620.4441)

(1r,4ar,5s)-5-{[(1r,2s,7s,8r,9r,13s)-8,15-dihydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-13-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C39H56O6 (620.4077)

3a,8-bis(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,5-dien-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

1-({1-[2-(2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}(methyl)carbamoyl)-2-methylbutyl 2-(dimethylamino)-4-methylpentanoate

C33H56N4O7 (620.4149)

[(1s,4s,5r,9s,10r,13r,14s)-5-formyl-14-hydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl (1s,4s,5r,9s,10r,13r,14r)-5-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate

C40H60O5 (620.4441)

2-[5,13-dihydroxy-7,14-dimethyl-15-(15-methylhexadecan-2-yl)-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C33H56N4O7 (620.4149)

4,8a-bis(hydroxymethyl)-4,6a,6b,11,12,14b-hexamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

annomosin a

C40H60O5 (620.4441)

{"Ingredient_id": "HBIN016218","Ingredient_name": "annomosin a","Alias": "NA","Ingredient_formula": "C40H60O5","Ingredient_Smile": "CC1(CCCC2(C1CCC34C2CCC(C3)C(C4)C(=O)OCC5(CC67CCC8C(CCCC8(C6CCC5C7)C)(C)C=O)O)C)C=O","Ingredient_weight": "620.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1309","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "637019","DrugBank_id": "NA"}

(2s,3r,4s,5r,6r)-6-{[(2r,3r,4s,5s,6r)-2-butoxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl hexadecanoate

C32H60O11 (620.4135)

5-(5,6-dimethylhept-3-en-2-yl)-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-yl 2-hydroxy-4-methoxy-6-propylbenzoate

C39H56O6 (620.4077)

3-[(3s,3as,4r,5ar,6s,7s,9ar,9br)-4-{[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C36H60O8 (620.4288)

(3r,5r)-5-[(11r)-11-hydroxy-11-[(2r,5r)-5-[(1r,4z)-1-hydroxypentadec-4-en-1-yl]oxolan-2-yl]-5-oxoundecyl]-3-(2-oxopropyl)oxolan-2-one

C37H64O7 (620.4652)

3-{13-hydroxy-13-[5'-(1-hydroxy-5-oxoundecyl)-[2,2'-bioxolan]-5-yl]tridecyl}-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

3-[(3r,3ar,4r,5as,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C36H60O8 (620.4288)

(5ar,6r,7s,9ar)-6-{2-[(1r,3ar,5z,8ar)-1,4,4,6-tetramethyl-1-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-hexahydro-2h-azulen-5-ylidene]ethyl}-7-hydroxy-2,2,5a,7-tetramethyl-hexahydro-1-benzoxepin-3-one

C36H60O8 (620.4288)

8-hydroxy-16-[3-hydroxy-4-(6-isopropyl-2-methoxy-5-methyloxan-2-yl)pentan-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C36H60O8 (620.4288)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2e)-6-methylhepta-2,5-dien-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

8-hydroxy-16-[3-hydroxy-4-(4-hydroxy-6-isopropyl-2-methoxy-5-methyloxan-2-yl)pentan-2-yl]-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C36H60O8 (620.4288)

(5ar,6r,7s,9ar)-6-{2-[(1r,3ar,5z,6r,8ar)-1,4,4,6-tetramethyl-1-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-hexahydro-2h-azulen-5-ylidene]ethyl}-7-hydroxy-2,2,5a,7-tetramethyl-hexahydro-1-benzoxepin-3-one

C36H60O8 (620.4288)

(3e,5e,7r,8s,9s,11e,13e,15s,16r)-8-hydroxy-16-[(2s,3r,4s)-3-hydroxy-4-[(2r,4r,5s,6r)-4-hydroxy-6-isopropyl-2-methoxy-5-methyloxan-2-yl]pentan-2-yl]-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C36H60O8 (620.4288)

[(3s,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-3-hydroxy-8a-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-4-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

3-hydroxy-15-[2-methoxy-5-(1,2,3-trihydroxy-2-methylpropyl)oxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C36H60O8 (620.4288)

(3z,5e,7r,8s,9s,11e,13e,15s,16r)-8-hydroxy-16-[(2s,3r,4s)-3-hydroxy-4-[(2r,5s,6r)-6-isopropyl-2-methoxy-5-methyloxan-2-yl]pentan-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C36H60O8 (620.4288)

5-{[1-(5,6-dihydroxy-6-methylheptan-2-yl)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O8 (620.4288)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-5,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2e)-6-methylhepta-2,5-dien-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

3-{13-hydroxy-13-[5'-(1-hydroxyundecyl)-[2,2'-bioxolan]-5-yl]-3-oxotridecyl}-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

(2r,3r,4s,5s,6r)-2-{[(4r,4ar,6as,6br,8ar,9s,10s,12ar,12br,14bs)-10-hydroxy-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

2-{[7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,5-dien-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

[3-hydroxy-8a-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-4-yl]methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

(5s)-3-[(2r)-2-hydroxy-7-[(2r,2'r,5s,5'r)-5'-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-[2,2'-bioxolan]-5-yl]heptyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9br,11r,11ar)-11-hydroxy-1-[(2e,5s)-5-hydroxy-6-methylhepta-2,6-dien-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

2-{[8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

(3s,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

2-{[7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-2,5-dien-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

8-hydroxy-16-[3-hydroxy-4-(2-hydroxy-6-isopropyl-4-methoxy-5-methyloxan-2-yl)pentan-2-yl]-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C36H60O8 (620.4288)

2-[15-(heptadecan-2-yl)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C33H56N4O7 (620.4149)

3-[(3s,3ar,4r,5ar,6s,7s,9ar,9br)-4-{[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C36H60O8 (620.4288)

(5s)-3-[(13r)-13-hydroxy-13-[(2r,2'r,5r,5'r)-5'-[(1s)-1-hydroxyundecyl]-[2,2'-bioxolan]-5-yl]-8-oxotridecyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

3-(2-hydroxy-7-{5'-[5-(1-hydroxytridecyl)oxolan-2-yl]-[2,2'-bioxolan]-5-yl}heptyl)-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

(1s,1'r,5s,5'r,8'r,9s,9's,10's,11'r,14s,14's,15r,16r,17's,18'r,19r,21s)-10'-methoxy-5,5',7-trimethyl-20-oxa-7,7'-diazaspiro[heptacyclo[13.6.1.1⁵,⁹.0¹,¹².0⁴,¹¹.0¹⁴,¹⁶.0¹⁶,²¹]tricosane-19,12'-hexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane]-4(11),6',12-triene

C42H56N2O2 (620.4342)

(1s,2s,5r,6r,9r,10r,13s,15s)-5-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-yl 2-hydroxy-4-methoxy-6-propylbenzoate

C39H56O6 (620.4077)

(2r,3r,4s,5s,6r)-2-{[(3s,4s,4ar,6ar,6bs,8as,12r,12ar,14ar,14br)-12-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

5-{[(1r,3ar,5ar,7r,8r,9as,11ar)-1-[(2r,5r)-5,6-dihydroxy-6-methylheptan-2-yl]-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O8 (620.4288)

(2s)-2-[(1r,3r,6r,10s,11s,12r,14r)-10,12-dihydroxy-14-(hydroxymethyl)-3,10-dimethyltricyclo[9.3.0.0³,⁷]tetradec-7-en-6-yl]propyl (2s)-2-[(2r,3r,5r,6s)-2-hydroxy-3,5-dimethyl-6-[(2s)-3-oxohexan-2-yl]oxan-2-yl]propanoate

C36H60O8 (620.4288)

(3s)-5-{[(1r,3ar,5ar,7r,8r,9as,11ar)-1-[(2r,5r)-5,6-dihydroxy-6-methylheptan-2-yl]-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O8 (620.4288)

methyl 4-[9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carbonyloxy]-3-methoxybenzoate

C39H56O6 (620.4077)

(5s)-3-{[(2r,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1r)-1-hydroxypentadecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,4s,7s,9as,9bs,11ar)-7-hydroxy-1-[(2r,4r)-4-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

(2r,3r,4s,5s,6r)-2-{[(3s,4as,6ar,6bs,8s,8as,12as,14as,14br)-8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

2-[(9z)-5,13-dihydroxy-7,14-dimethyl-15-(15-methylhexadecan-2-yl)-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C33H56N4O7 (620.4149)

2-{[7-hydroxy-1-(4-hydroxy-6-methylhept-5-en-2-yl)-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

3-[(3s,3ar,4r,5as,6s,7s,9ar,9br)-4-{[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C36H60O8 (620.4288)

(2r,3r,4s,5s,6r)-2-{[(3s,4s,4ar,6ar,6br,8ar,9r,12ar,14ar,14br)-3,9-dihydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

(2r,3r,4s,5r,6r)-2-{[(3s,4as,6ar,6bs,8s,8as,12ar,14as,14br)-8-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

(5s)-3-{[(2s,5r)-5-[(8r)-8-hydroxy-8-[(2r,5r)-5-[(1r)-1-hydroxypentadecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

(1s,1'r,5s,5'r,8'r,9s,9'r,11's,14s,14'r,15r,16r,17's,18's,19r,21r)-5,5',7,7'-tetramethyl-20-oxa-7,7'-diazaspiro[heptacyclo[13.6.1.1⁵,⁹.0¹,¹².0⁴,¹¹.0¹⁴,¹⁶.0¹⁶,²¹]tricosane-19,12'-hexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane]-4(11),12-dien-6'-one

C42H56N2O2 (620.4342)

(2e)-4-carbamimidamido-2-methylbut-2-en-1-yl 4-{3-[n'-(3-methylbut-2-en-1-yl)carbamimidamido]propyl}-1-[n-(3-methylbut-2-en-1-yl)carbamimidoyl]-2h,3h,3ah,4h,5h,9bh-pyrrolo[3,2-c]quinoline-8-carboxylate

C33H52N10O2 (620.4274)

6-{[2-butoxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl hexadecanoate

C32H60O11 (620.4135)

(2r,3r,4s,5s,6r)-2-{[(1r,3s,3as,5as,5bs,6s,7as,9s,11as,13ar,13bs)-1,6-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

[(4s,5r,9s,10r,13r,14s)-5-formyl-14-hydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl (1r,4s,5r,9s,10r,13r,14r)-5-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate

C40H60O5 (620.4441)

5-{[(1r,3ar,7s,8r,9as,11ar)-1-[(2r,5r)-5,6-dihydroxy-6-methylheptan-2-yl]-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O8 (620.4288)

2-{[2-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-n,4-dimethylpentanamido)-1-hydroxy-4-methylpentylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C33H56N4O7 (620.4149)

(3s,4r,4ar,6ar,6bs,8as,11r,12s,12as,14ar,14br)-4,8a-bis(hydroxymethyl)-4,6a,6b,11,12,14b-hexamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

(5r)-3-[(13r)-13-hydroxy-13-[(2s,2'r,5s,5's)-5'-[(1s)-1-hydroxy-5-oxoundecyl]-[2,2'-bioxolan]-5-yl]tridecyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

2-{[10-hydroxy-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

2-{[12-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

2-[2-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-n,3-dimethylbutanamido)-n,4-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C33H56N4O7 (620.4149)

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-3-hydroxy-15-[(2s,3s,5r)-2-methoxy-5-[(1s,2s)-1,2,3-trihydroxy-2-methylpropyl]oxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C36H60O8 (620.4288)

3-[(5-{8-hydroxy-8-[5-(1-hydroxypentadecyl)oxolan-2-yl]-2-oxooctyl}oxolan-2-yl)methyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

3-[(3s,3ar,4r,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C36H60O8 (620.4288)

methyl 4-[(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carbonyloxy]-3-methoxybenzoate

C39H56O6 (620.4077)

2-({1,6-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

(3s,4ar,6ar,6bs,8ar,9r,11r,12s,12as,14ar,14br)-9-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

(5s)-3-[(13r)-13-hydroxy-13-[(2r,2'r,5s,5's)-5'-[(1s)-1-hydroxyundecyl]-[2,2'-bioxolan]-5-yl]-3-oxotridecyl]-5-methyl-5h-furan-2-one

C37H64O7 (620.4652)

(1s,2s)-1-{[(2s)-1-[(2s)-2-[(2s)-2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl](methyl)carbamoyl}-2-methylbutyl (2s)-2-(dimethylamino)-4-methylpentanoate

C33H56N4O7 (620.4149)

(2r)-2-[(3r,9e,14r,15r)-5,13-dihydroxy-7,14-dimethyl-15-[(2s)-15-methylhexadecan-2-yl]-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C33H56N4O7 (620.4149)

3-[3-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C36H60O8 (620.4288)

(1r,3as,5ar,5br,7ar,9r,10r,11ar,11br,13ar,13br)-10-hydroxy-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O6 (620.4077)

3-(4-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl)propanoic acid

C36H60O8 (620.4288)

(1s,2s)-1-{[(2s)-1-[(2r)-2-[(2r)-2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl](methyl)carbamoyl}-2-methylbutyl (2s)-2-(dimethylamino)-4-methylpentanoate

C33H56N4O7 (620.4149)

2-[10,12-dihydroxy-14-(hydroxymethyl)-3,10-dimethyltricyclo[9.3.0.0³,⁷]tetradec-7-en-6-yl]propyl 2-[2-hydroxy-3,5-dimethyl-6-(3-oxohexan-2-yl)oxan-2-yl]propanoate

C36H60O8 (620.4288)

(2r,3r,4s,5s,6r)-2-{[(1r,3s,3as,5as,5bs,6s,7ar,9s,11as,13ar,13bs)-1,6-dihydroxy-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2z)-6-methylhepta-2,5-dien-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O8 (620.4288)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(3r,25s,27r)-3,25,27-trihydroxyoctacosyl]oxy}oxane-3,4,5-triol

C34H68O9 (620.4863)

(5ar,6r,7s,9ar)-6-{2-[(1r,3ar,5z,6s,8ar)-1,4,4,6-tetramethyl-1-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-hexahydro-2h-azulen-5-ylidene]ethyl}-7-hydroxy-2,2,5a,7-tetramethyl-hexahydro-1-benzoxepin-3-one

C36H60O8 (620.4288)